Impact of insurance on hospital course and readmission after resection of benign meningioma

  • PDF / 965,171 Bytes
  • 10 Pages / 595.276 x 790.866 pts Page_size
  • 41 Downloads / 159 Views

DOWNLOAD

REPORT


CLINICAL STUDY

Impact of insurance on hospital course and readmission after resection of benign meningioma Blake M. Hauser   · Saksham Gupta1,2 · Edward Xu2 · Kyle Wu1 · Joshua D. Bernstock1 · Melissa Chua1 · Ayaz M. Khawaja2 · Timothy R. Smith1,2 · Ian F. Dunn3 · Regan W. Bergmark1,4,5 · Wenya Linda Bi1  Received: 13 April 2020 / Accepted: 2 July 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Introduction  Surgical outcomes and healthcare utilization have been shown to vary based on patient insurance status. We analyzed whether patients’ insurance affects case urgency for and readmission after craniotomy for meningioma resection, using benign meningioma as a model system to minimize confounding from the disease-related characteristics of other neurosurgical pathologies. Methods  We analyzed 90-day readmission for patients who underwent resection of a benign meningioma in the Nationwide Readmission Database from 2014–2015. Results  A total of 9783 meningioma patients with private insurance (46%), Medicare (39%), Medicaid (10%), self-pay (2%), or another scheme (3%) were analyzed. 72% of all cases were elective; with 78% of cases in privately insured patients being elective compared to 71% of Medicare (p > 0.05), 59% of Medicaid patients (OR 2.3, p